Epidemiology of achondroplasia: A population-based study in Europe.


Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
09 2019
Historique:
received: 09 04 2019
revised: 20 06 2019
accepted: 23 06 2019
pubmed: 12 7 2019
medline: 4 8 2020
entrez: 12 7 2019
Statut: ppublish

Résumé

Achondroplasia is a rare genetic disorder resulting in short-limb skeletal dysplasia. We present the largest European population-based epidemiological study to date using data provided by the European Surveillance of Congenital Anomalies (EUROCAT) network. All cases of achondroplasia notified to 28 EUROCAT registries (1991-2015) were included in the study. Prevalence, birth outcomes, prenatal diagnosis, associated anomalies, and the impact of paternal and maternal age on de novo achondroplasia were presented. The study population consisted of 434 achondroplasia cases with a prevalence of 3.72 per 100,000 births (95%CIs: 3.14-4.39). There were 350 live births, 82 terminations of pregnancy after prenatal diagnosis, and two fetal deaths. The prenatal detection rate was significantly higher in recent years (71% in 2011-2015 vs. 36% in 1991-1995). Major associated congenital anomalies were present in 10% of cases. About 20% of cases were familial. After adjusting for maternal age, fathers >34 years had a significantly higher risk of having infants with de novo achondroplasia than younger fathers. Prevalence was stable over time, but regional differences were observed. All pregnancy outcomes were included in the prevalence estimate with 80.6% being live born. The study confirmed the increased risk for older fathers of having infants with de novo achondroplasia.

Identifiants

pubmed: 31294928
doi: 10.1002/ajmg.a.61289
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1791-1798

Subventions

Organisme : JRC-EUROCAT Central Registry
Pays : International

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Alessio Coi (A)

Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Michele Santoro (M)

Institute of Clinical Physiology, National Research Council, Pisa, Italy.

Ester Garne (E)

Paediatric Department, Hospital Lillebaelt, Kolding, Denmark.

Anna Pierini (A)

Institute of Clinical Physiology, National Research Council, Pisa, Italy.
Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Marie-Claude Addor (MC)

Department of Woman-Mother-Child, University Medical Center CHUV, Lausanne, Switzerland.

Jean-Luc Alessandri (JL)

Pole Femme-Mère-Enfants, CHR Felix Guyon, CHU La Réunion, Saint-Denis, La Réunion, France.

Jorieke E H Bergman (JEH)

Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Fabrizio Bianchi (F)

Institute of Clinical Physiology, National Research Council, Pisa, Italy.
Fondazione Toscana Gabriele Monasterio, Pisa, Italy.

Ljubica Boban (L)

Children's Hospital Zagreb, Centre of Excellence for Reproductive and Regenerative Medicine, Medical School University of Zagreb, Zagreb, Croatia.

Paula Braz (P)

Epidemiology Department, National Institute of Health Doutor Ricardo Jorge, Lisbon, Portugal.

Clara Cavero-Carbonell (C)

Rare Diseases Research Unit, Foundation for the Promotion of Health and Biomedical Research in the Valencian Region, Valencia, Spain.

Miriam Gatt (M)

Malta Congenital Anomalies Register, Directorate for Health Information and Research, Guardamangia, Malta.

Martin Haeusler (M)

Medical University of Graz, Graz, Austria.

Kari Klungsøyr (K)

Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Division of Mental and Physical Health, Norwegian Institute of Public Health, Bergen, Norway.

Jennifer J Kurinczuk (JJ)

National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Monica Lanzoni (M)

European Commission, Joint Research Centre (JRC), Ispra, Italy.

Nathalie Lelong (N)

Paris Registry of Congenital Malformations, Inserm UMR 1153-Obstetrical, Perinatal and Pediatric Epidemiology Research Team (Epopé), Center for Epidemiology and Statistics Sorbonne Paris Cité, DHU Risks in pregnancy, Paris Descartes University, Paris, France.

Karen Luyt (K)

South West Congenital Anomaly Register (SWCAR), Bristol Medical School, University of Bristol, Bristol, United Kingdom.

Olatz Mokoroa (O)

Public Health Division of Gipuzkoa, Biodonostia Research Institute, Donostia-San Sebastian, Spain.

Carmel Mullaney (C)

HSE South East Area, Department of Public Health, Kilkenny, Ireland.

Vera Nelen (V)

Provinciaal Instituut voor Hygiene (PIH), Antwerp, Belgium.

Amanda J Neville (AJ)

IMER Registry (Emilia Romagna Registry of Birth Defects), Center for Clinical and Epidemiological Research, University of Ferrara Azienda Ospedaliero-Universitaria di Ferrara, Ferrara, Italy.

Mary T O'Mahony (MT)

HSE South (Cork & Kerry), Department of Public Health, Cork, Ireland.

Isabelle Perthus (I)

Auvergne Registry of Congenital Anomalies (CEMC-Auvergne), Department of Clinical Genetics, Centre de Référence des Maladies Rares, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France.

Judith Rankin (J)

Institute of Health & Society, Newcastle University/National Congenital Anomaly and Rare Disease Registration Service (NCARDRS), Public Health England, Newcastle upon Tyne, United Kingdom.

Anke Rissmann (A)

Malformation Monitoring Centre Saxony-Anhalt, Medical Faculty Otto-von-Guericke University, Magdeburg, Germany.

Florence Rouget (F)

Brittany Registry of Congenital Malformations, CHU Rennes, Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail)-UMR_S 1085, Rennes, France.

Bruno Schaub (B)

French West Indies Registry, Registre des Malformations des Antilles (REMALAN), Maison de la Femme de la Mère et de l'Enfant, University Hospital of Martinique, Fort-de-France, France.

David Tucker (D)

Congenital Anomaly Register & Information Service for Wales (CARIS), Public Health Wales, Swansea, United Kingdom.

Diana Wellesley (D)

Wessex Clinical Genetics Service, University Hospitals Southampton, Southampton, United Kingdom.

Katarzyna Wisniewska (K)

Department of Preventive Medicine, Epidemiology Unit, Poznan University of Medical Sciences, Poznan, Poland.

Nataliia Zymak-Zakutnia (N)

Khmelnytsky Perinatal Center, OMNI-Net Ukraine Birth Defects Program, Khmelnytsky, Ukraine.

Ingeborg Barišić (I)

Children's Hospital Zagreb, Centre of Excellence for Reproductive and Regenerative Medicine, Medical School University of Zagreb, Zagreb, Croatia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH